Filing Details
- Accession Number:
- 0001209191-23-028505
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-10 16:51:37
- Reporting Period:
- 2023-05-08
- Accepted Time:
- 2023-05-10 16:51:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1308547 | Dolby Laboratories Inc. | DLB | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1256708 | Andrew Mark Sherman | C/O Dolby Laboratories, Inc. 1275 Market Street San Francisco CA 94103 | Evp, Gen. Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-05-08 | 11,118 | $45.50 | 67,492 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2023-05-08 | 3,882 | $62.32 | 71,374 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-05-08 | 12,820 | $83.47 | 58,554 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-05-08 | 2,180 | $84.35 | 56,374 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2023-05-08 | 11,118 | $0.00 | 11,118 | $45.50 |
| Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2023-05-08 | 3,882 | $0.00 | 3,882 | $62.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-12-15 | No | 4 | M | Direct | |
| 22,998 | 2024-12-15 | No | 4 | M | Direct |
Footnotes
- Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest
- The shares were sold in multiple transactions at prices ranging from $83.07 to $84.015, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- The shares were sold in multiple transactions at prices ranging from $84.10 to $84.735, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- This option was originally granted for a total of 52,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
- This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares.
Billionaire Hedge Funds
